Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Disentangling brain functional network remodeling in corticobasal syndrome - A multimodal MRI study.

Ballarini T, Albrecht F, Mueller K, Jech R, Diehl-Schmid J, Fliessbach K, Kassubek J, Lauer M, Fassbender K, Schneider A, Synofzik M, Wiltfang J; FTLD Consortium Germany; 4RTNI, Otto M, Schroeter ML.

Neuroimage Clin. 2020;25:102112. doi: 10.1016/j.nicl.2019.102112. Epub 2019 Dec 2.

2.

Cognitive Performance and Psychological Distress in Breast Cancer Patients at Disease Onset.

Kaiser J, Dietrich J, Amiri M, Rüschel I, Akbaba H, Hantke N, Fliessbach K, Senf B, Solbach C, Bledowski C.

Front Psychol. 2019 Nov 15;10:2584. doi: 10.3389/fpsyg.2019.02584. eCollection 2019.

3.

Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness.

Teipel SJ, Kuper-Smith JO, Bartels C, Brosseron F, Buchmann M, Buerger K, Catak C, Janowitz D, Dechent P, Dobisch L, Ertl-Wagner B, Fließbach K, Haynes JD, Heneka MT, Kilimann I, Laske C, Li S, Menne F, Metzger CD, Priller J, Pross V, Ramirez A, Scheffler K, Schneider A, Spottke A, Spruth EJ, Wagner M, Wiltfang J, Wolfsgruber S, Düzel E, Jessen F, Dyrba M; DELCODE study group.

J Alzheimers Dis. 2019;72(2):455-465. doi: 10.3233/JAD-190446.

4.

Higher CSF Tau Levels Are Related to Hippocampal Hyperactivity and Object Mnemonic Discrimination in Older Adults.

Berron D, Cardenas-Blanco A, Bittner D, Metzger CD, Spottke A, Heneka MT, Fliessbach K, Schneider A, Teipel SJ, Wagner M, Speck O, Jessen F, Düzel E.

J Neurosci. 2019 Oct 30;39(44):8788-8797. doi: 10.1523/JNEUROSCI.1279-19.2019. Epub 2019 Sep 20.

5.

Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment.

Bainbridge WA, Berron D, Schütze H, Cardenas-Blanco A, Metzger C, Dobisch L, Bittner D, Glanz W, Spottke A, Rudolph J, Brosseron F, Buerger K, Janowitz D, Fliessbach K, Heneka M, Laske C, Buchmann M, Peters O, Diesing D, Li S, Priller J, Spruth EJ, Altenstein S, Schneider A, Kofler B, Teipel S, Kilimann I, Wiltfang J, Bartels C, Wolfsgruber S, Wagner M, Jessen F, Baker CI, Düzel E.

Alzheimers Dement (Amst). 2019 Sep 5;11:610-618. doi: 10.1016/j.dadm.2019.07.005. eCollection 2019 Dec.

6.

A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2.

Karsak M, Glebov K, Scheffold M, Bajaj T, Kawalia A, Karaca I, Rading S, Kornhuber J, Peters O, Diez-Fairen M, Frölich L, Hüll M, Wiltfang J, Scherer M, Riedel-Heller S, Schneider A, Heneka MT, Fliessbach K, Sharaf A, Thiele H, Lennarz M, Jessen F, Maier W, Kubisch C, Ignatova Z, Nürnberg P, Pastor P, Walter J, Ramirez A.

Hum Mutat. 2020 Jan;41(1):169-181. doi: 10.1002/humu.23904. Epub 2019 Sep 15.

PMID:
31464095
7.

MR fingerprinting as a diagnostic tool in patients with frontotemporal lobe degeneration: A pilot study.

Keil VC, Bakoeva SP, Jurcoane A, Doneva M, Amthor T, Koken P, Mädler B, Block W, Fimmers R, Fliessbach K, Hattingen E.

NMR Biomed. 2019 Nov;32(11):e4157. doi: 10.1002/nbm.4157. Epub 2019 Aug 8.

PMID:
31393654
8.

Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.

Miebach L, Wolfsgruber S, Polcher A, Peters O, Menne F, Luther K, Incesoy E, Priller J, Spruth E, Altenstein S, Buerger K, Catak C, Janowitz D, Perneczky R, Utecht J, Laske C, Buchmann M, Schneider A, Fliessbach K, Kalbhen P, Heneka MT, Brosseron F, Spottke A, Roy N, Teipel SJ, Kilimann I, Wiltfang J, Bartels C, Düzel E, Dobisch L, Metzger C, Meiberth D, Ramirez A, Jessen F, Wagner M.

Alzheimers Res Ther. 2019 Jul 31;11(1):66. doi: 10.1186/s13195-019-0515-y.

9.

[Anti-tau therapies-what can be expected?]

Fließbach K, McCormick C, Kaulen B, Schneider A.

Nervenarzt. 2019 Sep;90(9):891-897. doi: 10.1007/s00115-019-0758-7. Review. German.

PMID:
31332452
10.

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.

Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, Liu KY, Priovoulos N, Fliessbach K, Dahl MJ, Maaß A, Madelung CF, Meder D, Ehrenberg AJ, Speck O, Weiskopf N, Dolan R, Inglis B, Tosun D, Morawski M, Zucca FA, Siebner HR, Mather M, Uludag K, Heinsen H, Poser BA, Howard R, Zecca L, Rowe JB, Grinberg LT, Jacobs HIL, Düzel E, Hämmerer D.

Brain. 2019 Sep 1;142(9):2558-2571. doi: 10.1093/brain/awz193.

11.

Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.

Brueggen K, Dyrba M, Cardenas-Blanco A, Schneider A, Fliessbach K, Buerger K, Janowitz D, Peters O, Menne F, Priller J, Spruth E, Wiltfang J, Vukovich R, Laske C, Buchmann M, Wagner M, Röske S, Spottke A, Rudolph J, Metzger CD, Kilimann I, Dobisch L, Düzel E, Jessen F, Teipel SJ; DELCODE Study Group.

J Neurol. 2019 Oct;266(10):2465-2474. doi: 10.1007/s00415-019-09429-3. Epub 2019 Jun 21.

PMID:
31227891
12.

Level of education mitigates the impact of tau pathology on neuronal function.

Hoenig MC, Bischof GN, Onur ÖA, Kukolja J, Jessen F, Fliessbach K, Neumaier B, Fink GR, Kalbe E, Drzezga A, van Eimeren T; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1787-1795. doi: 10.1007/s00259-019-04342-3. Epub 2019 Jun 10.

PMID:
31183635
13.

Computed-tomography-guided biopsy in suspected spondylodiscitis: Single-center experience including 201 biopsy procedures.

Özmen D, Özkan N, Guberina N, Fliessbach K, Suntharalingam S, Theysohn J, Büchter M, Forsting M, Buer J, Dudda M, Jäger M, Wetter A.

Orthop Rev (Pavia). 2019 Mar 22;11(1):7793. doi: 10.4081/or.2019.7793. eCollection 2019 Feb 26.

14.

Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging.

Albrecht F, Mueller K, Ballarini T, Lampe L, Diehl-Schmid J, Fassbender K, Fliessbach K, Jahn H, Jech R, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Ludolph AC, Lyros E, Prudlo J, Schneider A, Synofzik M, Wiltfang J, Danek A, Otto M; FTLD-Consortium, Schroeter ML.

Cortex. 2019 Aug;117:33-40. doi: 10.1016/j.cortex.2019.02.015. Epub 2019 Feb 25.

15.

The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease.

Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Buerger K, Levin J, Duering M, Dichgans M, Suárez-Calvet M, Haass C, Gordon BA, Lim YY, Masters CL, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Milz E, Moreno-Grau S, Teipel S, Grothe MJ, Kilimann I, Rossor M, Fox N, Laske C, Chhatwal J, Falkai P, Perneczky R, Lee JH, Spottke A, Boecker H, Brosseron F, Fliessbach K, Heneka MT, Nestor P, Peters O, Fuentes M, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÁ, Metzger C, Bittner D, Salloway S, Danek A, Hassenstab J, Yakushev I, Schofield PR, Morris JC, Bateman RJ, Ewers M.

Mol Psychiatry. 2019 Mar 21. doi: 10.1038/s41380-019-0404-6. [Epub ahead of print]

16.

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.

Diehl-Schmid J, Licata A, Goldhardt O, Förstl H, Yakushew I, Otto M, Anderl-Straub S, Beer A, Ludolph AC, Landwehrmeyer GB, Levin J, Danek A, Fliessbach K, Spottke A, Fassbender K, Lyros E, Prudlo J, Krause BJ, Volk A, Edbauer D, Schroeter ML, Drzezga A, Kornhuber J, Lauer M; FTLDc Study Group, Grimmer T.

Transl Psychiatry. 2019 Jan 31;9(1):54. doi: 10.1038/s41398-019-0381-1.

17.

CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume.

Düzel E, Berron D, Schütze H, Cardenas-Blanco A, Metzger C, Betts M, Ziegler G, Chen Y, Dobisch L, Bittner D, Glanz W, Reuter M, Spottke A, Rudolph J, Brosseron F, Buerger K, Janowitz D, Fliessbach K, Heneka M, Laske C, Buchmann M, Nestor P, Peters O, Diesing D, Li S, Priller J, Spruth EJ, Altenstein S, Ramirez A, Schneider A, Kofler B, Speck O, Teipel S, Kilimann I, Dyrba M, Wiltfang J, Bartels C, Wolfsgruber S, Wagner M, Jessen F.

Alzheimers Dement (Amst). 2018 Nov 2;10:782-790. doi: 10.1016/j.dadm.2018.10.003. eCollection 2018.

18.

The applause sign in frontotemporal lobar degeneration and related conditions.

Schönecker S, Hell F, Bötzel K, Wlasich E, Ackl N, Süßmair C; German FTLD Consortium, Otto M, Anderl-Straub S, Ludolph A, Kassubek J, Huppertz HJ, Diehl-Schmid J, Riedl L, Roßmeier C, Fassbender K, Lyros E, Kornhuber J, Oberstein TJ, Fliessbach K, Schneider A, Schroeter ML, Prudlo J, Lauer M, Jahn H, Levin J, Danek A.

J Neurol. 2019 Feb;266(2):330-338. doi: 10.1007/s00415-018-9134-y. Epub 2018 Dec 1.

PMID:
30506397
19.

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase.

Oeckl P, Weydt P, Steinacker P, Anderl-Straub S, Nordin F, Volk AE, Diehl-Schmid J, Andersen PM, Kornhuber J, Danek A, Fassbender K, Fliessbach K; German Consortium for Frontotemporal Lobar Degeneration, Jahn H, Lauer M, Müller K, Knehr A, Prudlo J, Schneider A, Thal DR, Yilmazer-Hanke D, Weishaupt JH, Ludolph AC, Otto M.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):4-10. doi: 10.1136/jnnp-2018-318868. Epub 2018 Sep 17.

PMID:
30224549
20.

Serum neurofilament light chain in behavioral variant frontotemporal dementia.

Steinacker P, Anderl-Straub S, Diehl-Schmid J, Semler E, Uttner I, von Arnim CAF, Barthel H, Danek A, Fassbender K, Fliessbach K, Foerstl H, Grimmer T, Huppertz HJ, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Maler JM, Mayer B, Oeckl P, Prudlo J, Schneider A, Volk AE, Wiltfang J, Schroeter ML, Ludolph AC, Otto M; FTLDc study group.

Neurology. 2018 Oct 9;91(15):e1390-e1401. doi: 10.1212/WNL.0000000000006318. Epub 2018 Sep 12.

PMID:
30209235
21.

NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer.

Rick O, Reuß-Borst M, Dauelsberg T, Hass HG, König V, Caspari R, Götz-Keil G, Pfitzner J, Kerschgens C, Fliessbach K, Hoppe C.

Psychooncology. 2018 Aug;27(8):2016-2022. doi: 10.1002/pon.4763. Epub 2018 Jun 1.

PMID:
29771474
22.

Blood-derived integration-free iPS cell line UKBi011-A from a diagnosed male Alzheimer's disease patient with APOE ɛ4/ɛ4 genotype.

Peitz M, Bechler T, Thiele CC, Veltel M, Bloschies M, Fliessbach K, Ramirez A, Brüstle O.

Stem Cell Res. 2018 May;29:250-253. doi: 10.1016/j.scr.2018.04.011. Epub 2018 Apr 23.

23.

A language-based sum score for the course and therapeutic intervention in primary progressive aphasia.

Semler E, Anderl-Straub S, Uttner I, Diehl-Schmid J, Danek A, Einsiedler B, Fassbender K, Fliessbach K, Huppertz HJ, Jahn H, Kornhuber J, Landwehrmeyer B, Lauer M, Muche R, Prudlo J, Schneider A, Schroeter ML, Ludolph AC, Otto M; FTLD consortium.

Alzheimers Res Ther. 2018 Apr 25;10(1):41. doi: 10.1186/s13195-018-0345-3.

24.

Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients - An Atlas-Based Volumetric MRI Study.

Schönecker S, Neuhofer C, Otto M, Ludolph A, Kassubek J, Landwehrmeyer B, Anderl-Straub S, Semler E, Diehl-Schmid J, Prix C, Vollmar C, Fortea J; Deutsches FTLD-Konsortium, Huppertz HJ, Arzberger T, Edbauer D, Feddersen B, Dieterich M, Schroeter ML, Volk AE, Fließbach K, Schneider A, Kornhuber J, Maler M, Prudlo J, Jahn H, Boeckh-Behrens T, Danek A, Klopstock T, Levin J.

Front Aging Neurosci. 2018 Mar 15;10:45. doi: 10.3389/fnagi.2018.00045. eCollection 2018.

25.

Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.

Franzmeier N, Düzel E, Jessen F, Buerger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Teipel S, Kilimann I, Ramirez A, Rossor M, Jucker M, Chhatwal J, Spottke A, Boecker H, Brosseron F, Falkai P, Fliessbach K, Heneka MT, Laske C, Nestor P, Peters O, Fuentes M, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Kofler B, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÁ, Metzger C, Bittner D, Weiner M, Lee JH, Salloway S, Danek A, Goate A, Schofield PR, Bateman RJ, Ewers M.

Brain. 2018 Apr 1;141(4):1186-1200. doi: 10.1093/brain/awy008.

26.

Age-related functional changes in domain-specific medial temporal lobe pathways.

Berron D, Neumann K, Maass A, Schütze H, Fliessbach K, Kiven V, Jessen F, Sauvage M, Kumaran D, Düzel E.

Neurobiol Aging. 2018 May;65:86-97. doi: 10.1016/j.neurobiolaging.2017.12.030. Epub 2018 Jan 31.

27.

[Biomarker-based diagnostics of Alzheimer's disease : Concept of suspected non-Alzheimer pathology].

Fliessbach K, Schneider A.

Nervenarzt. 2018 Mar;89(3):345-358. doi: 10.1007/s00115-018-0488-2. German.

PMID:
29423820
28.

Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).

Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT, Janowitz D, Kilimann I, Laske C, Menne F, Nestor P, Peters O, Priller J, Pross V, Ramirez A, Schneider A, Speck O, Spruth EJ, Teipel S, Vukovich R, Westerteicher C, Wiltfang J, Wolfsgruber S, Wagner M, Düzel E.

Alzheimers Res Ther. 2018 Feb 7;10(1):15. doi: 10.1186/s13195-017-0314-2.

29.

Cognitive Complaints in Memory Clinic Patients and in Depressive Patients: An Interpretative Phenomenological Analysis.

Miebach L, Wolfsgruber S, Frommann I, Fließbach K, Jessen F, Buckley R, Wagner M.

Gerontologist. 2019 Mar 14;59(2):290-302. doi: 10.1093/geront/gnx208.

PMID:
29325011
30.

Networks of tau distribution in Alzheimer's disease.

Hoenig MC, Bischof GN, Seemiller J, Hammes J, Kukolja J, Onur ÖA, Jessen F, Fliessbach K, Neumaier B, Fink GR, van Eimeren T, Drzezga A.

Brain. 2018 Feb 1;141(2):568-581. doi: 10.1093/brain/awx353.

PMID:
29315361
31.

Effects of sculpture based art therapy in dementia patients-A pilot study.

Seifert K, Spottke A, Fliessbach K.

Heliyon. 2017 Nov 22;3(11):e00460. doi: 10.1016/j.heliyon.2017.e00460. eCollection 2017 Nov.

32.

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression.

Steinacker P, Verde F, Fang L, Feneberg E, Oeckl P, Roeber S, Anderl-Straub S, Danek A, Diehl-Schmid J, Fassbender K, Fliessbach K, Foerstl H, Giese A, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer GB, Lauer M, Pinkhardt EH, Prudlo J, Rosenbohm A, Schneider A, Schroeter ML, Tumani H, von Arnim CAF, Weishaupt J, Weydt P, Ludolph AC, Yilmazer Hanke D, Otto M; FTLDc study group.

J Neurol Neurosurg Psychiatry. 2018 Mar;89(3):239-247. doi: 10.1136/jnnp-2017-317138. Epub 2017 Nov 15.

PMID:
29142138
33.

Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.

Müller S, Preische O, Göpfert JC, Yañez VAC, Joos TO, Boecker H, Düzel E, Falkai P, Priller J, Buerger K, Catak C, Janowitz D, Heneka MT, Brosseron F, Nestor P, Peters O, Menne F, Schipke CG, Schneider A, Spottke A, Fließbach K, Kilimann I, Teipel S, Wagner M, Wiltfang J, Jessen F, Laske C.

Sci Rep. 2017 Aug 25;7(1):9529. doi: 10.1038/s41598-017-08779-0.

34.

Tau pathology and cognitive reserve in Alzheimer's disease.

Hoenig MC, Bischof GN, Hammes J, Faber J, Fliessbach K, van Eimeren T, Drzezga A.

Neurobiol Aging. 2017 Sep;57:1-7. doi: 10.1016/j.neurobiolaging.2017.05.004. Epub 2017 May 10.

PMID:
28577411
35.

Reduced future-oriented decision making in individuals with subjective cognitive decline: A functional MRI study.

Hu X, Uhle F, Fliessbach K, Wagner M, Han Y, Weber B, Jessen F.

Alzheimers Dement (Amst). 2017 Mar 14;6:222-231. doi: 10.1016/j.dadm.2017.02.005. eCollection 2017.

36.

Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning.

Voigt-Radloff S, de Werd MM, Leonhart R, Boelen DH, Olde Rikkert MG, Fliessbach K, Klöppel S, Heimbach B, Fellgiebel A, Dodel R, Eschweiler GW, Hausner L, Kessels RP, Hüll M.

Alzheimers Res Ther. 2017 Mar 23;9(1):22. doi: 10.1186/s13195-017-0247-9.

37.

Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias.

Steinacker P, Semler E, Anderl-Straub S, Diehl-Schmid J, Schroeter ML, Uttner I, Foerstl H, Landwehrmeyer B, von Arnim CA, Kassubek J, Oeckl P, Huppertz HJ, Fassbender K, Fliessbach K, Prudlo J, Roßmeier C, Kornhuber J, Schneider A, Volk AE, Lauer M, Danek A, Ludolph AC, Otto M; FTLDc Study Group.

Neurology. 2017 Mar 7;88(10):961-969. doi: 10.1212/WNL.0000000000003688. Epub 2017 Feb 8.

PMID:
28179468
38.

Choline-based imaging of prostate cancer with combined [18F] fluorocholine PET and 1H MR spectroscopy by means of integrated PET/MRI.

Wetter A, Grüneisen J, Fliessbach K, Lütje S, Schaarschmidt B, Umutlu L.

Clin Imaging. 2017 Mar - Apr;42:198-202. doi: 10.1016/j.clinimag.2016.12.008. Epub 2017 Jan 7.

PMID:
28110202
39.

Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease.

Bischof GN, Jessen F, Fliessbach K, Dronse J, Hammes J, Neumaier B, Onur O, Fink GR, Kukolja J, Drzezga A, van Eimeren T; Alzheimer's Disease Neuroimaging Initiative.

Ann Clin Transl Neurol. 2016 Oct 20;3(12):934-939. doi: 10.1002/acn3.339. eCollection 2016 Dec.

40.

In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.

Dronse J, Fliessbach K, Bischof GN, von Reutern B, Faber J, Hammes J, Kuhnert G, Neumaier B, Onur OA, Kukolja J, van Eimeren T, Jessen F, Fink GR, Klockgether T, Drzezga A.

J Alzheimers Dis. 2017;55(2):465-471.

PMID:
27802224
41.

Stochastic resonance therapy induces increased movement related caudate nucleus activity.

Kaut O, Becker B, Schneider C, Zhou F, Fliessbach K, Hurlemann R, Wüllner U.

J Rehabil Med. 2016 Oct 12;48(9):815-818. doi: 10.2340/16501977-2143.

42.

Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia.

Teipel S, Raiser T, Riedl L, Riederer I, Schroeter ML, Bisenius S, Schneider A, Kornhuber J, Fliessbach K, Spottke A, Grothe MJ, Prudlo J, Kassubek J, Ludolph A, Landwehrmeyer B, Straub S, Otto M, Danek A; FTLDc study group.

Cortex. 2016 Oct;83:124-35. doi: 10.1016/j.cortex.2016.07.004. Epub 2016 Jul 16.

43.

Neuronal correlates of social decision making are influenced by social value orientation-an fMRI study.

Kuss K, Falk A, Trautner P, Montag C, Weber B, Fliessbach K.

Front Behav Neurosci. 2015 Feb 24;9:40. doi: 10.3389/fnbeh.2015.00040. eCollection 2015.

44.

Silent music reading: auditory imagery and visuotonal modality transfer in singers and non-singers.

Hoppe C, Splittstößer C, Fliessbach K, Trautner P, Elger CE, Weber B.

Brain Cogn. 2014 Nov;91:35-44. doi: 10.1016/j.bandc.2014.08.002. Epub 2014 Sep 15.

PMID:
25222292
45.

Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.

Thelen M, Razquin C, Hernández I, Gorostidi A, Sánchez-Valle R, Ortega-Cubero S, Wolfsgruber S, Drichel D, Fliessbach K, Duenkel T, Damian M, Heilmann S, Slotosch A, Lennarz M, Seijo-Martínez M, Rene R, Kornhuber J, Peters O, Luckhaus C, Jahn H, Hüll M, Rüther E, Wiltfang J, Lorenzo E, Gascon J, Lleó A, Lladó A, Campdelacreu J, Moreno F, Ahmadzadehfar H; Dementia Genetics Spanish Consortium (DEGESCO), Fortea J, Indakoetxea B, Heneka MT, Wetter A, Pastor MA, Riverol M, Becker T, Frölich L, Tárraga L, Boada M, Wagner M, Jessen F, Maier W, Clarimón J, López de Munain A, Ruiz A, Pastor P, Ramirez A.

Neurobiol Aging. 2014 Nov;35(11):2657.e13-2657.e19. doi: 10.1016/j.neurobiolaging.2014.06.018. Epub 2014 Jun 20.

PMID:
25042114
46.

Neural patterns underlying social comparisons of personal performance.

Lindner M, Rudorf S, Birg R, Falk A, Weber B, Fliessbach K.

Soc Cogn Affect Neurosci. 2015 Apr;10(4):569-76. doi: 10.1093/scan/nsu087. Epub 2014 Jun 18.

47.

The influence of status on satisfaction with relative rewards.

Albrecht K, von Essen E, Fliessbach K, Falk A.

Front Psychol. 2013 Oct 30;4:804. doi: 10.3389/fpsyg.2013.00804. eCollection 2013.

48.

Effort increases sensitivity to reward and loss magnitude in the human brain.

Hernandez Lallement J, Kuss K, Trautner P, Weber B, Falk A, Fliessbach K.

Soc Cogn Affect Neurosci. 2014 Mar;9(3):342-9. doi: 10.1093/scan/nss147. Epub 2012 Nov 30.

49.

Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors.

Semmler A, Widmann CN, Okulla T, Urbach H, Kaiser M, Widman G, Mormann F, Weide J, Fliessbach K, Hoeft A, Jessen F, Putensen C, Heneka MT.

J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):62-9. doi: 10.1136/jnnp-2012-302883. Epub 2012 Nov 7.

PMID:
23134661
50.

Neural responses to advantageous and disadvantageous inequity.

Fliessbach K, Phillipps CB, Trautner P, Schnabel M, Elger CE, Falk A, Weber B.

Front Hum Neurosci. 2012 Jun 8;6:165. doi: 10.3389/fnhum.2012.00165. eCollection 2012.

Supplemental Content

Loading ...
Support Center